Adam H Golden
About
Provided by Adam H Golden
Practice Areas
Head of the US Life Sciences Transactions practice and based in New York, Adam Golden advises life sciences companies on their most important transactions. Clients turn to Adam for his dual skillset, which combines his strengths as a mergers and acquisitions and corporate lawyer, with those of an intellectual property transactions lawyer. This enables him to represent pharmaceutical, biotechnology, and medical device companies in the full scope of transactions that are common to this sector.
Career
J.D., New York University School of Law, 1990; A.B., Princeton University, 1986
Articles, highlights and press releases
1 item provided by Freshfields Bruckhaus Deringer
Hogan Lovells advises Shire in ex-U.S. closing of its US$2.4bn business sale to Servier S.A.S.
Hogan Lovells represented global biotechnology company Shire plc. in the ex-U.S. closing of the sale of its oncology business to Servier S.A.S., an independent international pharmaceutical company, for US$2.4 billion in cash.
Hogan Lovells advises Shire in ex-U.S. closing of its US$2.4bn business sale to Servier S.A.S.
Hogan Lovells represented global biotechnology company Shire plc. in the ex-U.S. closing of the sale of its oncology business to Servier S.A.S., an independent international pharmaceutical company, for US$2.4 billion in cash.
Discover other Lawyers at
Freshfields Bruckhaus Deringer
Africa-wide
Austria
Bahrain
Belgium
Key Sectors
Provided by Freshfields Bruckhaus Deringer
Health and Life Sciences